{{Rsnum
|rsid=1996656
|Chromosome=12
|position=102358184
|Orientation=plus
|GMAF=0.1497
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 0.0 | 0.0 | 0.0
| HCB | 65.9 | 31.8 | 2.3
| JPT | 61.4 | 36.4 | 2.3
| YRI | 76.2 | 23.8 | 0.0
| ASW | 0.0 | 0.0 | 0.0
| CHB | 65.9 | 31.8 | 2.3
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=19858071
|Title=Common Genetic Variation in IGF1, IGFBP1, and IGFBP3 and Ovarian Cancer Risk
|OA=1
}}

{{PMID Auto
|PMID=17300730
|Title=Common genetic variation in IGF1, IGFBP-1, and IGFBP-3 in relation to mammographic density: a cross-sectional study.
|OA=1
}}

{{PMID Auto
|PMID=18596909
|Title=IGF-1, IGFBP-1, and IGFBP-3 polymorphisms predict circulating IGF levels but not breast cancer risk: findings from the Breast and Prostate Cancer Cohort Consortium (BPC3).
|OA=1
}}

{{PMID Auto
|PMID=19124510
|Title=Insulin-like growth factor-1- and interleukin-6-related gene variation and risk of multiple myeloma.
|OA=1
}}

{{PMID Auto
|PMID=19551864
|Title=Genetic variation and circulating levels of IGF-I and IGFBP-3 in relation to risk of proliferative benign breast disease.
|OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}